Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Experimental Hematology|February 24, 1999
Detection and quantitation of genetically marked acute myeloid leukemia by competitive polymerase chain reaction after autologous bone marrow transplantation: a preclinical model for minimal residual diseaseT Kühr, O Bechter, S Geley, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomographyT Traub-Weidinger, E Von Guggenberg, G Dobrozemsky, et al.
Journal of Cancer Research and Clinical Oncology|May 14, 2013
The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS)F Ploner, W Lamm, S Schur, et al.
The Journal of Clinical Investigation|February 13, 2001
Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null miceH Glimm, W Eisterer, K Lee, et al.
Leukemia Research|October 31, 2001
CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myelomaW Eisterer, O Bechter, W Hilbe, et al.
Leukemia Research|June 27, 2000
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot studyT Kühr, W Eisterer, U Apfelbeck, et al.
Blood|October 15, 1996
Different CD44 splicing patterns define prognostic subgroups in multiple myelomaR Stauder, M Van Driel, C Schwärzler, et al.
Oncology|January 19, 2013
Feasibility of a multdisciplinary lung cancer videoconference between a peripheral hospital and a comprehensive cancer centreA Seeber, M Mitterer, E Gunsilius, et al.
Experimental Hematology|September 16, 2000
Transplantation of IL-2-transduced murine bone marrow is associated with dose-dependent toxicityT Kühr, O Bechter, S Dirnhofer, et al.
Leukemia|January 28, 2005
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human diseaseW Eisterer, X Jiang, O Christ, et al.
Pageof 4